Certolizumab Subcutaneous and Recombinate recombinant
Determining the interaction of Certolizumab Subcutaneous and Recombinate recombinant and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: certolizumab
Brand name: Cimzia, Cimzia Starter
Synonyms: Certolizumab, Certolizumab Pegol
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Recombinate (recombinant), Recombinate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Certolizumab Subcutaneous-Recombivax
- Certolizumab Subcutaneous-Recombivax HB
- Certolizumab Subcutaneous-Recombivax HB Adult
- Certolizumab Subcutaneous-Recombivax HB Dialysis Formulation
- Certolizumab Subcutaneous-Recombivax HB Pediatric/Adolescent
- Certolizumab Subcutaneous-Recort Plus
- Recombinate recombinant-Certolizumab Vials
- Recombinate recombinant-Cerubidine
- Recombinate recombinant-Cervarix
- Recombinate recombinant-Cervarix Intramuscular
- Recombinate recombinant-Cervidil
- Recombinate recombinant-Cesamet